Integron-mediated rifampin resistance in Pseudomonas aeruginosa

Area of Science:

• Microbiology
• Genetics
• Molecular Biology

Background:

• Rifampin is a crucial antibiotic for treating various bacterial infections.
• The emergence of antibiotic resistance poses a significant threat to public health.
• Understanding novel resistance mechanisms is vital for developing effective treatment strategies.

Purpose of the Study:

• To identify and characterize new genes conferring rifampin resistance in Pseudomonas aeruginosa.
• To elucidate the molecular basis of rifampin resistance mediated by the novel arr-2 gene.

Main Methods:

• Genomic analysis of Pseudomonas aeruginosa isolates.
• Sequence analysis and comparison of the identified arr-2 gene and its protein product.
• Investigating the genetic context of the arr-2 gene, including its location within integrons.

Main Results:

• Discovery of a new rifampin resistance gene, designated arr-2, in Pseudomonas aeruginosa.
• The ARR-2 protein shares significant amino acid identity (54%) with a known rifampin ADP-ribosylating transferase from Mycobacterium smegmatis.
• The arr-2 gene is situated on a gene cassette within a class I integron, suggesting potential for horizontal gene transfer.

Conclusions:

• The identification of arr-2 provides a new mechanism of rifampin resistance in Pseudomonas aeruginosa.
• The genetic context of arr-2 within an integron highlights its potential role in the dissemination of antibiotic resistance.
• Further research into ARR-2 function and prevalence is warranted to inform clinical management and drug development.